Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$8.49 +0.53 (+6.68%)
As of: Oct 21, 2026 · 10:42 AM EDT

Cumberland Pharmaceuticals (CPIX) Finished Goods (2011 - 2012)

Updated

Cumberland Pharmaceuticals' Finished Goods came in at $4.91 million for Q4 2012, down 1.8% from $5 million a year earlier.

Analysis

Cumberland Pharmaceuticals (CPIX) Finished Goods (2011 - 2012) Analysis & Trends

  • Going back by year, Finished Goods was $5 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.10 Bn 1,100.69 Bn 19.71 Bn
2 Johnson & Johnson 615.67 Bn 534.20 Bn 17.26 Bn
3 AbbVie 504.61 Bn 477.72 Bn 12.70 Bn
4 Merck 368.03 Bn 322.41 Bn 12.21 Bn
5 Novartis Ag 298.24 Bn 262.23 Bn 11.24 Bn
6 Astrazeneca 261.77 Bn 235.46 Bn 12.86 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.81 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cumberland Pharmaceuticals 127.19 Mn 85.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 4.91 Mn
Dec 31, 2011 5.00 Mn
API Access

Cumberland Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=CPIX&period=max&api_key=YOUR_API_KEY